1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
Time since infarct by enhancement
Time Since InfarctEnhancement
NoneMildStrongTotal
Acute phase (0–4 weeks)0 (0%)0 (0%)16 (100%)16 (55.2%)
Subacute phase (4–12 weeks)1 (20%)3 (60%)1 (20%)5 (17.2%)
Chronic phase (>12 weeks)4 (50%)3 (37.5%)1 (12.5%)8 (27.6%)
Total5 (17.2%)6 (20.7%)18 (62.1%)29 (100%)
  • Note:—Fisher exact test for count data, P value = 2.8 × 10−6. Spearman correlation = −0.84 (95% CIs −0.92, −0.70).